These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35579347)

  • 21. Role of the NLRP3 inflammasome in a model of acute burn-induced pain.
    Deuis JR; Yin K; Cooper MA; Schroder K; Vetter I
    Burns; 2017 Mar; 43(2):304-309. PubMed ID: 28040362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
    Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
    Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.
    Frising UC; Ribo S; Doglio MG; Malissen B; van Loo G; Wullaert A
    EMBO Rep; 2022 Jul; 23(7):e54339. PubMed ID: 35574994
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CAPS and NLRP3.
    Booshehri LM; Hoffman HM
    J Clin Immunol; 2019 Apr; 39(3):277-286. PubMed ID: 31077002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B
    Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo.
    Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y
    Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.
    Lee GS; Subramanian N; Kim AI; Aksentijevich I; Goldbach-Mansky R; Sacks DB; Germain RN; Kastner DL; Chae JJ
    Nature; 2012 Dec; 492(7427):123-7. PubMed ID: 23143333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
    Aróstegui JI
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model.
    Ma JH; Lee E; Yoon SH; Min H; Oh JH; Hwang I; Sung Y; Ryu JH; Bok J; Yu JW
    EBioMedicine; 2022 Aug; 82():104184. PubMed ID: 35870427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and pharmacological inhibition of inflammasomes reduces the survival of Mycobacterium tuberculosis strains in macrophages.
    Subbarao S; Sanchez-Garrido J; Krishnan N; Shenoy AR; Robertson BD
    Sci Rep; 2020 Feb; 10(1):3709. PubMed ID: 32111888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis.
    McElvaney OJ; Zaslona Z; Becker-Flegler K; Palsson-McDermott EM; Boland F; Gunaratnam C; Gulbins E; O'Neill LA; Reeves EP; McElvaney NG
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1381-1391. PubMed ID: 31454256
    [No Abstract]   [Full Text] [Related]  

  • 38. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
    Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
    J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetics of cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB; Lohse P
    Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome.
    Kaneko N; Kurata M; Yamamoto T; Shigemura T; Agematsu K; Yamazaki T; Takeda H; Sawasaki T; Koga T; Kawakami A; Yachie A; Migita K; Yoshiura KI; Urano T; Masumoto J
    Sci Rep; 2020 Aug; 10(1):13562. PubMed ID: 32782316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.